Form D · Other Health Care
Accendo Therapeutics, Inc.
Carlsbad, CA · CIK 0001538384
Offering snapshot reported Dec 29, 2011 · SEC filing
- Reported sold
- $3.99M Offering amount: $4M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Dec 16, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2011 | Initial | $3,990,017 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170906
Source: Form D, filed Dec 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Noah Knauf | Director |
| Richard Mott | Director |
| Arthur T. Taylor | Executive |
| Elizabeth Weatherman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
6190 Corte Del Cedro
Carlsbad, CA, 92011
Carlsbad, CA, 92011